These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 27385648)

  • 1. Discrimination, HIV among People Who Use Drugs, and the UNGASS 2016 on the World Drug Problem.
    Tinasti K; Ravishankar S; Zuniga JM
    J Int Assoc Provid AIDS Care; 2016 Jul; 15(4):273-5. PubMed ID: 27385648
    [No Abstract]   [Full Text] [Related]  

  • 2. UNGASS: time to put HIV at the forefront of drug policy.
    Lancet HIV; 2016 Apr; 3(4):e147. PubMed ID: 27036984
    [No Abstract]   [Full Text] [Related]  

  • 3. Reducing harm in the community.
    Katiforis R
    Aust Nurs J; 2007 Nov; 15(5):37. PubMed ID: 18044243
    [No Abstract]   [Full Text] [Related]  

  • 4. The future of harm reduction programmes in Russia.
    Lancet; 2009 Oct; 374(9697):1213. PubMed ID: 19819371
    [No Abstract]   [Full Text] [Related]  

  • 5. "We don't need services. We have no problems": exploring the experiences of young people who inject drugs in accessing harm reduction services.
    Krug A; Hildebrand M; Sun N
    J Int AIDS Soc; 2015; 18(2 Suppl 1):19442. PubMed ID: 25724510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. UNGASS 2016 on drugs, the first challenge for HIV advocates in the post-2015 era.
    Fordham A; Tinasti K
    J Int AIDS Soc; 2014; 17(1):19274. PubMed ID: 25053452
    [No Abstract]   [Full Text] [Related]  

  • 7. State of the art science addressing injecting drug use, HIV and harm reduction.
    Beg M; Strathdee SA; Kazatchkine M
    Int J Drug Policy; 2015 Feb; 26 Suppl 1():S1-4. PubMed ID: 25727257
    [No Abstract]   [Full Text] [Related]  

  • 8. Progress or backsliding on HIV and illicit drugs in 2008?
    Csete J; Wolfe D
    Lancet; 2008 May; 371(9627):1820-1. PubMed ID: 18514715
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of HIV prevention interventions for people who inject drugs in low- and middle-income countries--the current and future state of the art.
    Hammett TM; Parsons DS
    Int J Drug Policy; 2014 May; 25(3):336-9. PubMed ID: 24559603
    [No Abstract]   [Full Text] [Related]  

  • 10. Improving the data to strengthen the global response to HIV among people who inject drugs.
    Mathers B; Cook C; Degenhardt L
    Int J Drug Policy; 2010 Mar; 21(2):100-2. PubMed ID: 20144539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Policy change towards implementing harm reduction in Sub-Saharan Africa.
    Abdool R
    Int J Drug Policy; 2016 Apr; 30():140-2. PubMed ID: 27017377
    [No Abstract]   [Full Text] [Related]  

  • 12. The U.N. system issues calls to strengthen harm reduction interventions.
    HIV AIDS Policy Law Rev; 2009 Dec; 14(2):31-2. PubMed ID: 20225514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global Fund investments in harm reduction from 2002 to 2009.
    Bridge J; Hunter BM; Atun R; Lazarus JV
    Int J Drug Policy; 2012 Jul; 23(4):279-85. PubMed ID: 22421551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Harm reduction in Asia and the Pacific: an evolving public health response.
    Crofts N; Azim T
    Harm Reduct J; 2015 Oct; 12():47. PubMed ID: 26471163
    [No Abstract]   [Full Text] [Related]  

  • 15. Harm reduction interventions should encompass people who inject image and performance enhancing drugs.
    McVeigh J; Kimergård A; Bates G; Hope VD; Ncube F
    BMJ; 2016 Apr; 353():i1889. PubMed ID: 27048560
    [No Abstract]   [Full Text] [Related]  

  • 16. Health Canada commits to strengthening efforts with respect to injection drug use and HIV/AIDS.
    Jürgens R
    Can HIV AIDS Policy Law Rev; 2001; 6(1-2):86-9. PubMed ID: 11837044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human rights and universal access for men who have sex with men and people who inject drugs: a qualitative analysis of the 2010 UNGASS narrative country progress reports.
    Persson A; Ellard J; Newman C; Holt M; de Wit J
    Soc Sci Med; 2011 Aug; 73(3):467-74. PubMed ID: 21764488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV treatment, injection drug use, and illicit drug policies.
    Wood E; Kerr T; Montaner JS
    Lancet; 2007 Jul; 370(9581):8-10. PubMed ID: 17617253
    [No Abstract]   [Full Text] [Related]  

  • 19. Islam and harm reduction.
    Kamarulzaman A; Saifuddeen SM
    Int J Drug Policy; 2010 Mar; 21(2):115-8. PubMed ID: 20006483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Could a United Nations organisation lead to a worsening of drug-related harms?
    Wood E; Kerr T
    Drug Alcohol Rev; 2010 Jan; 29(1):99-100. PubMed ID: 20078689
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.